甲状腺激素激活酶,DIO2,是一种潜在的泛癌生物标志物和免疫治疗点
A Nappi1, C Miro2, A G Cicatiello2
1Department of Clinical Medicine and Surgery, University of Naples "Federico II", 80131, Naples, Italy. annarita.nappi@unina.it.
Journal of endocrinological investigation
|January 17, 2025
概括
对于甲状腺激素激活至关重要的DIO2基因在许多癌症中表达高,并且与瘤进展有关. 这表明DIO2可能作为人类癌症的预后标志物.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 2型二氧激酶 (D2) 将甲状腺素 (T4) 激活为三甲状腺素 (T3),调节细胞内甲状腺激素 (TH) 的可用性.
- 通过D2增加周围TH激活与瘤进展,转移和免疫调节有关.
- DIO2基因编码D2酶,在TH代谢中发挥关键作用.
研究的目的:
- 研究D2在人类癌症中的临床相关性.
- 使用癌症基因图谱 (TCGA) 数据库对DIO2基因表达进行泛癌分析.
- 探索DIO2表达,瘤微环境 (TME) 组件和免疫细胞透之间的关联.
主要方法:
- 来自TCGA数据的各种癌症类型中DIO2表达的泛癌症分析.
- 研究DIO2表达和TME特征之间的相关性.
- 分析DIO2表达和免疫细胞透模式之间的关系.
- 检查DIO2基因变异类型及其影响.
主要成果:
- 发现DIO2在大多数分析的瘤中表达高,尽管表达水平各不相同.
- DIO2表达与某些瘤类型的进展相关.
- 在DIO2表达和TME成分,免疫细胞透和免疫基因子集 (抑制和刺激) 之间观察到显著的关联.
结论:
- 这项研究为D2活性促进瘤入侵的发现提供了临床相关性.
- DIO2基因成为各种人类癌症的潜在预后生物标志物.
- 了解DIO2的作用可以为癌症诊断和治疗策略提供信息.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
637
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12.3K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
01:46Electron Transport Chain: Complex I and II
10.8K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.8K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K